[Electrophysiological study of the cardiotropic action of phenothiazine-derivative anti-arrhythmia preparations]. 1986

Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova

Cardiotropic action of antiarrhythmic agents etmozin and etacizin, phenothiazine derivatives, was studied electrophysiologically in 42 mongrel dogs (using isolated heart and intact body models). Etmozin produced no direct effect on sinus node function, whereas etacizin suppressed it in isolated hearts. Etmozin and etacizin significantly affected the atrial, atrioventricular-node and His-Purkinje conduction time, having no basic effect on the duration of respective refractory periods. Therefore, they can be referred to antiarrhythmic agents, group 1, subclass C. The magnitude and pattern of etmozin-and etacizin-induced electrophysiologic changes in the isolated heart and the integrated system are basically similar, an evidence of cardiotropic effects of these drugs. The model of an isolated dog heart perfused by a donor dog's blood can be used for the assessment of cardiotropic effects of drugs in preclinical trials of new antiarrhythmic agents.

UI MeSH Term Description Entries
D008297 Male Males
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1979, Farmakologiia i toksikologiia,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1980, Sovetskaia meditsina,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1986, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1980, Farmakologiia i toksikologiia,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
November 1986, Kardiologiia,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
November 1985, Nihon rinsho. Japanese journal of clinical medicine,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
August 1991, Biulleten' eksperimental'noi biologii i meditsiny,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1975, Farmakologiia i toksikologiia,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1983, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
Kh Kh Shugushev, and L V Rozenshtraukh, and V F Portnoĭ, and G F Dvortsin, and A V Iushmanova
January 1984, Terapevticheskii arkhiv,
Copied contents to your clipboard!